非酒精性脂肪肝
脂质过氧化
活性氧
脂质代谢
GPX4
疾病
发病机制
脂肪肝
程序性细胞死亡
医学
氧化应激
癌症研究
药理学
化学
内科学
生物化学
细胞凋亡
过氧化氢酶
谷胱甘肽过氧化物酶
作者
Shengnan Zhao,Guo Yan,Xunzhe Yin
标识
DOI:10.31083/j.fbl2812332
摘要
Nonalcoholic fatty liver disease (NAFLD) constitutes a commonly diagnosed liver pathology with perturbed lipid metabolism, which is mainly caused by excessive accumulation of fat in hepatocytes by various pathogenic factors. Currently, there are no effective drug treatments for NAFLD. Ferroptosis represents a novel form of programmed cell death depending on iron, which is driven by large cellular amounts of reactive oxygen species (ROS) and lipid peroxides. Ferroptosis plays critical regulatory roles in the pathogenesis of NAFLD, and overaccumulation of Fe2+ contributes to lipid peroxidation, which subsequently aggravates NAFLD. Therefore, ferroptosis suppression might constitute an important target for NAFLD treatment. This article reviews the discovery, production pathways, and defense mechanisms of ferroptosis, and explores its association with NAFLD. This may provide new reference targets and strategies for the development of NAFLD drugs from the perspective of ferroptosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI